1Brudno Y,Ennett-Shepard AB,Chen RR,et al.Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials . 2013
2Ciardiello F,Caputo R,Damiano V,et al.Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Clinical Cancer Research . 2003
3Nakabayashi Hiromichi,Yawata Toshio,Shimizu Keiji.Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells. BMC Cancer . 2010
4Andrea Wang-Gillam,Eric Siegel,Debra A. Mayes,Laura F. Hutchins,Yi-Hong Zhou.Anti-Tumor Effect of Doxycycline on Glioblastoma Cells. Journal of Cancer Molecules . 2007
5Reardon David A,Vredenburgh James J,Desjardins Annick,Peters Katherine,Gururangan Sridharan,Sampson John H,Marcello Jennifer,Herndon James E,McLendon Roger E,Janney Dorothea,Friedman Allan H,Bigner Darell D,Friedman Henry S.Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma. Journal of Neurocytology . 2010
6Knizetova P,Ehrmann J,Hlobilkova A,et al.Autocrine regulation of glioblastoma cell cycle progression,viability and radioresistance through the VEGF-VEGFR2 (KDR)interplay. Cell Cycle . 2008
8Schwartzbaum Judith A,Fisher James L,Aldape Kenneth D,Wrensch Margaret.Epidemiology and molecular pathology of glioma. Nature clinical practice. Neurology . 2006
9Hands JR,Abel P,Ashton K,et al.Investigating the rapid diagnosis of gliomas from serum samples using infrared spectrostroscopy and cytokine and angiogenesis factors. Analytical and Bioanalytical Chemistry . 2013
10Stalker L,Pemberton J,Moorehead RA.Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors. Cancer Cell International . 2014
1Rahmah NN, Sakai K, Sano K, et al. Expression of RECK in endothelial ceUs of glioma: comparison with CD34 and VEGF expressions[J]. J Neurooncol, 2012, 107 (3) :559-564.
2Kim BS, Kim SK, Choi SH, et al. Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas[J]. J Neurooncol, 2015, 124(1) : 101-110.
3Aparicio-Blanco J,Torres-Suarez AI. Glioblastoma Multiforme and Lip- id Nanocapsules : A Review [ J ]. J Biomed Nanotechno1,2015,11 ( 8 ) : 1283-1311.
4Nitta M, Muragaki Y, Maruyama T, et al. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection [ J ]. Neurosurg Focus ,2015,38 ( 1 ) : E7.
5Abdulla S, Saada J, Johnson G, et al. Turnout progression or pseudo- progression? A review of post-treatment radiological appearances of glioblastoma [ J ]. Clin Radiol,2015,70 ( 11 ) : 1299 -1312.
6Mangraviti A, Tyler B, Brem H. Interstitial chemotherapy for malignant glioma:Future prospects in the era of multimodal therapy [ J ]. Surg Neurol Int ,2015,6 ( Suppl 1 ) : $78-$84.
7Kapoor DN, Bhatia A, Kaur R, et al. PLGA : a unique polymer for drug delivery[ J]. Ther Deliv ,2015,6( 1 ) :41-58.
8Husseini GA, Pitt WG, Martins AM. Ultrasonically triggered drug de- livery : breaking the barrier [ J ]. Colloids Surf B Biointerfaces, 2014, 123 ( 11 ) :364-386.
9Akash MS, Rehman K. Recent progress in biomedical applications of Pluronie ( PF127 ) : Pharmaceutical perspectives [ J ]. J Control Re- lease ,2015,209 (7) : 120-138.
10Shi J, Zhang Y, Fu WM, et al. Establishment of C6 brain glioma mod- els through stereotactic technique for laser interstitial thermotherapy re- search [ J ]. Surg Neurol Int,2015,6 (4) :51-68.
